About this role
About the Role A postdoctoral position is available in the laboratory of Gordon Freeman in the Department of Medical Oncology at the Dana-Farber Cancer Institute, Harvard Medical School. The lab focuses on costimulatory and coinhibitory pathways, particularly the PD-L1/PD-1 and HHLA2/KIR3DL3 pathways. This position will involve examining the role of PD-1 and other coinhibitory pathways in immune responses and particularly on therapeutic synergies of coinhibitory blockade for anti-tumor immunity. What You'll Do
- Design and conduct experiments to investigate PD-1 and other coinhibitory pathways in immune responses.
- Assess therapeutic synergies of coinhibitory blockade for anti-tumor immunity.
- Analyze immunological data and contribute to publications, while collaborating with other lab members.
- Work with T cells, antigen-presenting cells, and perform assays including cell culture, immunological techniques, and multicolor flow cytometry; may involve scRNA analysis. What We're Looking For
- Ph.D. and/or M.D. required.
- Background in immunology and mouse tumor models essential.
- Experience with T cells, antigen-presenting cells, cell culture, immunological techniques, multicolor flow cytometry; scRNA analysis highly desirable. Nice to Have
- Experience with single-cell RNA sequencing (scRNA-seq) analysis is highly desirable. Compensation & Benefits
- Salary range: $72,000 - $76,385 per year.
- Employment Type: Full-time, onsite.